Impact of Thrombocytopenia on Survival in Patients with Hepatocellular Carcinoma: Updated Meta-Analysis and Systematic Review

被引:1
|
作者
Kraj, Leszek [1 ,2 ]
Chmiel, Paulina [3 ]
Gryziak, Maciej [1 ]
Grabowska-Derlatka, Laretta [4 ]
Szymanski, Lukasz [2 ]
Wysokinska, Ewa [5 ]
机构
[1] Med Univ Warsaw, Univ Clin Ctr, Dept Oncol, PL-02091 Warsaw, Poland
[2] Polish Acad Sci, Inst Genet & Anim Biotechnol, Dept Mol Biol, PL-01447 Magdalenka, Poland
[3] Med Univ Warsaw, Univ Clin Ctr, PL-02091 Warsaw, Poland
[4] Med Univ Warsaw, Univ Clin Ctr, Dept Clin Radiol 2, PL-02091 Warsaw, Poland
[5] Mayo Clin, Div Hematol & Med Oncol, Jacksonville, FL 32224 USA
关键词
hepatocellular carcinoma; HCC; thrombocytopenia; platelets; outcome; tumor features; ENDOTHELIAL GROWTH-FACTOR; FACTOR-RECEPTOR-ALPHA; PLATELET COUNT; RADIOFREQUENCY ABLATION; PROGNOSTIC-FACTOR; POOR-PROGNOSIS; HEPATITIS-B; CANCER; RESECTION; SIZE;
D O I
10.3390/cancers16071293
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Simple Summary: Currently, hepatocellular carcinoma (HCC) is one of the most prevalent oncological diagnoses worldwide. Despite intensive research into its pathogenesis and clinical course, numerous issues remain unresolved. In the presented meta-analysis and systematic review, we investigate the potential of blood platelet levels in patients with HCC for prognostic assessment. Blood platelets may play a significant role as an easily measurable laboratory parameter in assessing the prognosis of patients with HCC. Background: Platelets (PLT) have a role in the pathogenesis, progression, and prognosis of hepatocellular carcinoma (HCC) and could represent a readily measurable laboratory parameter to enhance the comprehensive evaluation of HCC patients. Methods: The PubMed, Web of Science, and Scopus databases were searched with a focus on survival as well as patient and tumor-specific characteristics in correlation to reported PLT counts. Survival outcomes were analyzed with both common-effect and random-effects models. The hazard ratio (HR) and its 95% confidence interval (CI) from analyzed trials were incorporated. Studies that did not provide survival data but focused on platelet count correlation with HCC characteristics were reviewed. Results: In total, 26 studies, including a total of 9403 patients, met our criteria. The results showed that thrombocytopenia in HCC patients was associated with poor overall survival (common-effect HR = 1.15, 95% CI: 1.06-1.25; random-effect HR = 1.30, 95% CI: 1.05-1.63). Moreover, three studies reveal significant correlations between PLT indices and tumor characteristics such as size, foci number, and etiology of HCC development. Conclusion: Our meta-analysis confirmed that PLT count could act as a prognostic marker in HCC, especially with a PLT count cut off <100 x 10(3)/mm(3). Further prospective studies focusing on the role of PLT in clearly defined subgroups are necessary.
引用
收藏
页数:16
相关论文
共 50 条
  • [21] Radiofrequency ablation versus laparoscopic hepatectomy for hepatocellular carcinoma: a systematic review and meta-analysis
    Jiang, Chuang
    Feng, Qingbo
    Zhang, Zhihong
    Qiang, Zeyuan
    Du, Ao
    Xu, Lin
    Li, Jiaxin
    WORLD JOURNAL OF SURGICAL ONCOLOGY, 2024, 22 (01)
  • [22] The predictive value of tumor infiltrating leukocytes in Hepatocellular Carcinoma: A systematic review and meta-analysis
    Schoenberg, Markus Bo
    Li, Xiaokang
    Li, Xinyu
    Han, Yongsheng
    Hao, Jingcheng
    Miksch, Rainer Christoph
    Koch, Dominik
    Boerner, Nikolaus
    Beger, Nicola Theresa
    Bucher, Julian Nikolaus
    Schiergens, Tobias Simon
    Guba, Markus Otto
    Werner, Jens
    V. Bazhin, Alexandr
    EJSO, 2021, 47 (10): : 2561 - 2570
  • [23] Neoadjuvant immunotherapy for resectable hepatocellular carcinoma: a systematic review and meta-analysis
    Han, Y. -H.
    Bo, J. -Q.
    Liu, L. -X.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2023, 27 (15) : 7134 - 7147
  • [24] Systematic Review and Meta-analysis: Association of Aspirin With Incidence of Hepatocellular Carcinoma
    Zhou, Xueliang
    Zhang, Tengfei
    Sun, Yali
    Li, Chunwei
    Ding, Xianfei
    Zhu, Yanhui
    Li, Lifeng
    Fan, Zhirui
    FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [25] Risk factors for hepatocellular carcinoma: an umbrella review of systematic review and meta-analysis
    Wang, Jie
    Qiu, Kaijie
    Zhou, Songsheng
    Gan, Yichao
    Jiang, Keting
    Wang, Donghuan
    Wang, Haibiao
    ANNALS OF MEDICINE, 2025, 57 (01)
  • [26] Neoadjuvant Immune Checkpoint Inhibitors for Resectable Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis
    Zhao, Mei
    Chen, Shanwen
    Li, Conggui
    Du, Yingying
    Li, Ping
    CANCERS, 2023, 15 (03)
  • [27] Hepatic Resection Improved the Long-Term Survival of Patients with BCLC Stage B Hepatocellular Carcinoma in Asia: a Systematic Review and Meta-Analysis
    Liu, Wei
    Zhou, Jian-Guo
    Sun, Yi
    Zhang, Lei
    Xing, Bao-Cai
    JOURNAL OF GASTROINTESTINAL SURGERY, 2015, 19 (07) : 1271 - 1280
  • [28] Salvage liver transplantation versus curative treatment for patients with recurrent hepatocellular carcinoma: A systematic review and meta-analysis
    Liu, Junning
    Zhang, Guangnian
    Yang, Linfeng
    Yan, Duan
    Yu, Jiahui
    Wei, Song
    Li, Jijiang
    Yi, Pengsheng
    EJSO, 2024, 50 (07):
  • [29] Myosteatosis and the survival of patients with hepatocellular carcinoma: a meta-analysis
    Yongjuan Wu
    Guangyuan Cheng
    Jun Han
    Qingsong Yang
    Clinical and Experimental Medicine, 25 (1)
  • [30] Microvessel Density and Impact of Angiogenesis on Survival of Resected Pancreatic Cancer Patients A Systematic Review and Meta-analysis
    Ntellas, Panagiotis
    Dadouli, Katerina
    Perivoliotis, Konstantinos
    Sogka, Eleni
    Pentheroudakis, Georgios
    Ioannou, Maria
    Hadjichristodoulou, Christos
    Tepetes, Konstantinos
    Mauri, Davide
    PANCREAS, 2019, 48 (02) : 233 - 241